Rituxan Hycela ratings & reviews

Rituximab (Murine), Hyaluronidase (Human recombinant)
Company: Genentech
Brand: Rituxan Hycela
Drug class: Antineoplastic and Immunomodulating Agents
+4 more
Antineoplastic and Immunomodulating Agents, Antineoplastics, Antineoplastic Monoclonal Antibodies, Antineoplastic Monoclonal Antibodies Targeting Cluster of Differentiation (CD) Antigens, Antineoplastic Monoclonal Antibodies Targeting CD20
Overall rating
3.7
full star full star full star half star empty star
Ranked #7
Physician ratings
  • Efficacy: effective for its intended use
  • Safety: safe to use in humans
  • Tolerability: low drug side effects
  • Accessibility: insurance/payer coverage, cost, affordability,formulary coverage, availability in your hospital or practice setting
  • Adherence: patient compliance with treatment
Efficacy
3.8/5
Safety
3.7/5
Tolerability
3.7/5
Accessibility
3.7/5
Adherence
3.6/5

Sermo AI Overview

  • Rituxan Hycela is generally viewed as a convenient formulation of rituximab that retains efficacy, with strong support from specialists for its effectiveness in treating non-Hodgkin's lymphoma and positive patient experiences regarding administration ease.
  • Despite positive feedback from many oncologists, some professionals express concerns about Rituxan Hycela's overall effectiveness and its positioning as a primary treatment option for chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
  • Accessibility and safety ratings of Rituxan Hycela vary among specialists, with some believing it is less effective compared to other treatments, indicating potential limitations in its use for certain patient populations.
  • A subset of specialists, particularly from certain regions, have raised concerns about Rituxan Hycela's efficacy relative to other options, suggesting it may not be a viable alternative for all patients.
  • Was this summary helpful?
Based on insights from Sermo’s triple verified physicians

Description

Rituxan Hycela is a combination of rituximab and hyaluronidase human. Rituximab is a monoclonal antibody directed against the CD20 antigen. It is formulated as an injection for subcutaneous administration and comes in single-dose vials containing specific concentrations. Key inactive ingredients include L-histidine, polysorbate 80, and α,α-trehalose dihydrate.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is for injection under the skin. It is given by a care team in a hospital or clinic setting.

A special MedGuide will be given to you before each treatment. Be sure to read this information carefully each time.

Talk to your care team about the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions or angioedema—skin rash, itching or hives, swelling of the face, eyes, lips, tongue, arms, or legs, trouble swallowing or breathing
  • Bowel blockage—stomach cramping, unable to have a bowel movement or pass gas, loss of appetite, vomiting
  • Dizziness, loss of balance or coordination, confusion or trouble speaking
  • Fever, chills, unusual weakness or fatigue, loss of appetite, nausea, headache, dizziness, feeling faint or lightheaded, shortness of breath, fast or irregular heartbeat, which may be signs of cytokine release syndrome
  • Heart attack—pain or tightness in the chest, shoulders, arms, or jaw, nausea, shortness of breath, cold or clammy skin, feeling faint or lightheaded
  • Heart rhythm changes—fast or irregular heartbeat, dizziness, feeling faint or lightheaded, chest pain, trouble breathing
  • Infection—fever, chills, cough, sore throat, wounds that don't heal, pain or trouble when passing urine, general feeling of discomfort or being unwell
  • Kidney injury—decrease in the amount of urine, swelling of the ankles, hands, or feet
  • Liver injury—right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, unusual weakness or fatigue
  • Redness, blistering, peeling, or loosening of the skin, including inside the mouth
  • Stomach pain that is severe, does not go away, or gets worse
  • Tumor lysis syndrome (TLS)—nausea, vomiting, diarrhea, decrease in the amount of urine, dark urine, unusual weakness or fatigue, confusion, muscle pain or cramps, fast or irregular heartbeat, joint pain

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

  • Constipation
  • Fatigue
  • Hair loss
  • Nausea
  • Pain, redness, or irritation at injection site

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

  • Heart disease
  • Immune system problems
  • Infection, such as hepatitis B, chickenpox, cold sores, herpes
  • Irregular heartbeat
  • Kidney disease
  • Lung or breathing disease, such as asthma
  • Recently received or scheduled to receive a vaccine
  • An unusual or allergic reaction to rituximab, rituximab;hyaluronidase, mouse proteins, other medications, foods, dyes, or preservatives
  • Pregnant or trying to get pregnant
  • Breast-feeding

What may interact with this medication?

Do not take this medication with any of the following:

  • Live virus vaccines

This medication may also interact with the following:

  • Cisplatin

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Your condition will be monitored carefully while you are receiving this medication. You may need blood work while taking this medication.

This medication can cause serious allergic reactions. To reduce the risk, your care team may give you other medications to take before receiving this one. Be sure to follow the directions from your care team.

In some patients, this medication may cause a serious brain infection that may cause death. If you have any problems seeing, thinking, speaking, walking, or standing, tell your care team right away. If you cannot reach your care team, urgently seek other source of medical care.

This medication may increase your risk of getting an infection. Call your care team for advice if you get a fever, chills, sore throat, or other symptoms of a cold or flu. Do not treat yourself. Try to avoid being around people who are sick.

Talk to your care team if you may be pregnant. Serious birth defects can occur if you take this medication during pregnancy and for 12 months after the last dose. Your will need a negative pregnancy test before starting this medication. Contraception is recommended while taking this medication and for 12 months after the last dose. Your care team can help you find the option that works for you.

Do not breastfeed while taking this medication and for at least 6 months after the last dose.

What are the most serious risks of this medication?

This medicine can cause severe, life-threatening neurologic problems.

If you have ever had hepatitis B, you may get a flare-up or return of the hepatitis during use of this medicine. Your healthcare provider will monitor your liver function. You will need to discontinue this medicine and take other medicines if your hepatitis flares-up or returns.

This medication may cause rare but serious skin rashes.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

  3. Authorized User acknowledges and agrees that the Elsevier Products are designed for and are intended to be used by those residing in the United States, and that the information contained in the Elsevier Products does not comply with any laws or practices outside of the United States. You assume all responsibilities, duties, and obligations for any treatment, decision, or advice made or given to third parties as a result of the use or application of the Elsevier Products outside of the United States, and Sermo, Elsevier and its affiliates, subsidiaries, agents and suppliers will incur no liability for any use or application of the Products by Authorized Users outside of the United States.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence